BeStock  
Stocks › Biotechnology › BLTE

Belite Bio BLTE

US equityMarket cap rank #2018Biotechnology
$127.38 −$23.64 (-15.65%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $127.38 0.00%
Open$129.00
Prev close$151.02
Day range$120.00 – $135.07
Volume1.04M
Market cap$5.17B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-57.9x
CheapRich

Below its usual level · 40th percentile, 5-year average -57.2x

Price / book8.7x
CheapRich

Near the bottom of its 5-year range · 19th percentile, 5-year average 11.3x

#4861 of 5331 stocks by PB (1 = cheapest)

P/E over five years

-117x-81x-44x-8xApr '22Aug '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$156.06
Price vs. fair value-18.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 8.66 – 11.31 19% (cheaper than usual) #4861 of 5331 (1 = cheapest)
PE -57.87 -85.50 -57.19 40% (cheaper than usual) –
PS – 38.46 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on BLTE.

Sign in to join the discussion.

Scroll to Top